Cookie use on MRCVSonline
We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive all cookies.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Manuscript calls for collaborative approach to drug development
"We hope our recommendations will reposition comparative oncology canine trials as integral and parallel to human development" - Dr Chand Khanna.
Manuscript will further new initiatives to expand awareness of comparative oncology.

A new WSAVA-supported manuscript has highlighted the value of collaboration between the human and animal pharmaceutical and biotech sectors in drug development.

The manuscript follows a workshop on comparative oncology, hosted by the WSAVA's One Health Committee (WSAVA OHC) at its 2019 World Congress in Toronto. The workshop was led by researchers in human and animal medicine and was attended by academics and industry representatives working in cancer research.

Many cancers that afflict dogs also occur in humans, giving researchers the chance to improve lives by studying cancers and treatments in parallel. Delegates at the workshop included other members of the WSAVA OHC, academics and industry representatives working in cancer research.

In the manuscript, researchers outline new commercial perspectives on the value of closer relationships between the human and animal health pharmaceutical and biotech sectors, to deliver a ‘win/win’ for successful cancer drug development in humans and dogs.

Manuscript author Dr Chand Khanna, from the American College of Veterinary Internal Medicine (Oncology), commented: “We hope our recommendations will reposition comparative oncology canine trials as integral and parallel to human development and that this move will create opportunities for step-wise iteration and the improvements in the human cancer drug development path that are increasingly necessary.”

Dr Michael Lappin, chair of WSAVA One Health Committee, added: “The field of comparative oncology as part of cancer drug development stands out as a successful example of the One Health approach to medicine and this new manuscript presents a nuanced and novel strategy to deliver this translational opportunity.”

The authors and the WSAVA OHC plan to use the manuscript as a springboard for further new initiatives to expand awareness of comparative oncology. They also hope to drive forward its use to create a closer alignment of human and animal health pharma and biotech.

The manuscript, entitled ‘Delivering innovation to oncology drug development through cancer drug DISCO (Development Incentive Strategy using comparative oncology): Perspectives, gaps and solutions’, is published in the journal Annals of Medicine and Clinical Oncology

Become a member or log in to add this story to your CPD history

Kennel Club appoints new chief executive

News Story 1
 The Kennel Club has announced the appointment of Mark Beazley, who was previously Cats Protection's director of operations, as chief executive. Mark replaces Rosemary Smart, who stepped down from the role in April after 18 years.

Mark has held several senior strategic and executive roles, including executive director at Dogs Trust Ireland and chair of the Companion Animal Working Group at Eurogroup for Animals. He was also heavily involved in the establishment of the Eu Cat and Dog Alliance.

Mark will take up his new role in October. 

Click here for more...
News Shorts
International Cat Care appoints new head of veterinary division

International Cat Care (ICC) has announced the appointment of Nathalie Dowgray as head of the charity's veterinary division.

Nathalie, who is an RCVS advanced practitioner in feline medicine, will lead the International Society of Feline Medicine (ISFM) and a play key role in advancing knowledge and research in feline medicine.

Claire Bessant, iCatCare's chief executive said: "We're absolutely delighted to be welcoming Nathalie to the charity. She brings a depth and breadth of feline expertise and understanding which fits perfectly with the charity's work and development, and her enthusiasm for cats is infectious."